Kunxian Yang

421 total citations
19 papers, 320 citations indexed

About

Kunxian Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kunxian Yang has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Kunxian Yang's work include Cancer-related molecular mechanisms research (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Kunxian Yang is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Kunxian Yang collaborates with scholars based in China and Pakistan. Kunxian Yang's co-authors include Wenru Tang, Jingyu Yang, Li Li, Ying Luo, Jianjun Wang, Yaping Liu, Yun‐Li Zhao, Xing‐Wei Yang, Xiao‐Dong Luo and Lu Liu and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Kunxian Yang

18 papers receiving 313 citations

Peers

Kunxian Yang

ONCOL

PRM

Christina Nadolny United States

Xiaoming Shi China

Xueyan Wu China

Yukihiro Hirata Japan

Boxing Su China

Marjaneh Farazestanian Iran

Yangqiu Bai China

Jiao Xiao China

Mingzhu Bai China

Christina Nadolny United States

Kunxian Yang

146 ×0.8

86 ×1.0

109 ×1.6

ONCOL

21 ×0.6

PRM

16 ×0.5

Citations per year, relative to Kunxian Yang Kunxian Yang (= 1×) peers Christina Nadolny

Countries citing papers authored by Kunxian Yang

Since Specialization

Citations

This map shows the geographic impact of Kunxian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunxian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunxian Yang more than expected).

Fields of papers citing papers by Kunxian Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunxian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunxian Yang. The network helps show where Kunxian Yang may publish in the future.

Co-authorship network of co-authors of Kunxian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Kunxian Yang. A scholar is included among the top collaborators of Kunxian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunxian Yang. Kunxian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jiang, Peng, Songshan Jiang, Yuxin Zhao, et al.. (2025). Long non-coding RNA MIR22HG impedes the progression of anaplastic thyroid carcinoma via targeting miR-141-3p/PTEN/AKT axis. Endokrynologia Polska. 76(4). 385–396.

Yang, Kunxian, et al.. (2024). miRNA‐449c‐5p regulates the JAK‐STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2. Cancer Reports. 7(2). e1974–e1974. 4 indexed citations

Yu, Yuyang, et al.. (2022). Alternative Lengthening of Telomeres and Mediated Telomere Synthesis. Cancers. 14(9). 2194–2194. 14 indexed citations

Li, Li, Jianjun Wang, Zhongquan Li, et al.. (2021). Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma. Cancer Management and Research. Volume 13. 6517–6525. 10 indexed citations

Liu, Chen‐Jian, et al.. (2021). The comparison of microbial communities in thyroid tissues from thyroid carcinoma patients. The Journal of Microbiology. 59(11). 988–1001. 14 indexed citations

Wang, Jianjun, Kunxian Yang, Junyu Cao, & Li Li. (2021). Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner. Bioengineered. 12(2). 10624–10637. 13 indexed citations

Li, Li, Jianjun Wang, Junyu Cao, et al.. (2021). Effect and Mechanism of Ulinastatin Gold Nanoparticles on Proliferation and Migration of Human Breast Cancer Cells. Science of Advanced Materials. 13(10). 1839–1848. 1 indexed citations

Qiu, Shuang, Juan Peng, Jia Liu, et al.. (2020). LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway. FEBS Open Bio. 10(5). 817–826. 34 indexed citations

Li, Li, et al.. (2020). Peripheral Blood Leukocytes and Platelets Serve as Prognostic Factors in Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 36(2). 167–173. 11 indexed citations

10.

Zeng, Rong, et al.. (2020). FoxP3 promotes lymph node metastasis in patients with papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis. Translational Cancer Research. 9(3). 1337–1350. 5 indexed citations

11.

Zhao, Yuan, et al.. (2020). Application of circulating tumor DNA in breast cancer. The Breast Journal. 26(9). 1797–1800. 5 indexed citations

12.

Li, Li, et al.. (2018). Distribution and prognostic value of tumor‑infiltrating T cells in breast cancer. Molecular Medicine Reports. 18(5). 4247–4258. 24 indexed citations

13.

Yang, Jingyu, et al.. (2017). The relationship between RASSF1A promoter methylation and thyroid carcinoma. Medicine. 96(46). e8630–e8630. 16 indexed citations

14.

Yang, Jingyu, et al.. (2016). A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis. PLoS ONE. 11(5). e0149185–e0149185. 23 indexed citations

15.

Wang, Fang, Shanshan Li, Kunxian Yang, et al.. (2016). Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis. The Breast. 28. 45–53. 23 indexed citations

16.

Chen, Yingying, Kunxian Yang, Xing‐Wei Yang, et al.. (2016). New Cytotoxic Tigliane Diterpenoids from Croton caudatus. Planta Medica. 82(8). 729–733. 19 indexed citations

17.

Wu, Xiaoming, Kunxian Yang, Xiaodan Tang, et al.. (2015). Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis. Journal of Assisted Reproduction and Genetics. 32(5). 797–805. 47 indexed citations

18.

Li, Qiong, Kunxian Yang, Yun‐Li Zhao, et al.. (2015). Potent anti-inflammatory and analgesic steroidal alkaloids from Veratrum taliense. Journal of Ethnopharmacology. 179. 274–279. 43 indexed citations

19.

Yang, Kunxian, et al.. (2014). The Prognosis of MGMT Promoter Methylation in Glioblastoma Patients of Different Race: A Meta-analysis. Neurochemical Research. 39(12). 2277–2287. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact